# Clinical Evidence Based and TCM Phenotype Group Study of Zhilong Huoxue Tongyu Capsule in the Treatment of Stable Angina Pectoris of Coronary Heart Disease (Qi Deficiency and Blood Stasis Syndrome)

> **NCT06709638** · PHASE2 · UNKNOWN · sponsor: **Jiang Hanmei** · enrollment: 230 (estimated)

## Conditions studied

- Coronary Heart Disease (CHD)

## Interventions

- **OTHER:** Placebo Comparator
- **DRUG:** Zhilong Huoxue Tongyu capsule

## Key facts

- **NCT ID:** NCT06709638
- **Lead sponsor:** Jiang Hanmei
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06709638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06709638, "Clinical Evidence Based and TCM Phenotype Group Study of Zhilong Huoxue Tongyu Capsule in the Treatment of Stable Angina Pectoris of Coronary Heart Disease (Qi Deficiency and Blood Stasis Syndrome)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06709638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*